Applied BioMath
Concord · Founded 2013
About Applied BioMath
Applied BioMath helps biotechnology and pharmaceutical companies accelerate and de-risk drug research and development. Its goal is to reduce late-stage attrition by applying advanced mathematical and systems biology techniques at critical decision points in the drug discovery process. They accomplish this by employing internally developed algorithms where systems approach naturally drive quantitative decisions to provide customers with a thorough understanding of the optimal way forward with their drug discovery efforts. Through high-performance computational biology and large dataset analyses, their predictive models provide best-in-industry insight allowing our customers to realize the most cost-effective method for drug discovery. The company was founded in 2013 by Dr. John Burke, Dr. Joshua Apgar, and Andrew Sutherland.
Company Facts
- Founded: 2013
- Legal name: Applied BioMath, LLC.
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $505.2K
- Funding stage: M&A
- Last round: Grant (Aug 2023)
- Website: appliedbiomath.com
- Phone: +1 (617) 914-8800
Social Profiles
Canonical: https://fsome.com/organization/applied-biomath-8404409 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.